Sökning: onr:"swepub:oai:DiVA.org:liu-164029" >
Association of high...
Association of high-density lipoprotein particle concentration with cardiovascular risk following acute coronary syndrome: A case-cohort analysis of the dal-Outcomes trial
-
- Salahuddin, Taufiq (författare)
- VA Med Ctr, CO 80045 USA; Univ Colorado, CO USA
-
- Kittelson, John (författare)
- VA Med Ctr, CO 80045 USA
-
- Tardif, Jean-Claude (författare)
- Univ Montreal, Canada
-
visa fler...
-
- Shah, Prediman K. (författare)
- Cedars Sinai Med Ctr, CA 90048 USA
-
- Olsson, Anders, 1940- (författare)
- Linköpings universitet,Avdelningen för diagnostik och specialistmedicin,Medicinska fakulteten
-
- Nicholls, Stephen J. (författare)
- Monash Univ, Australia
-
- Leitersdorf, Eran (författare)
- Hadassah Hebrew Univ, Israel
-
- Leiter, Lawrence A. (författare)
- Univ Toronto, Canada
-
- Kallend, David (författare)
- Medicines Co, Switzerland
-
- Black, Donald M. (författare)
- Dalcor Pharmaceut, Switzerland
-
- Barter, Philip J. (författare)
- Univ New South Wales, Australia
-
- Ballantyne, Christie M. (författare)
- Baylor Coll Med, TX 77030 USA
-
- Schwartz, Gregory G. (författare)
- VA Med Ctr, CO 80045 USA; Univ Colorado, CO USA
-
visa färre...
-
(creator_code:org_t)
- MOSBY-ELSEVIER, 2020
- 2020
- Engelska.
-
Ingår i: American Heart Journal. - : MOSBY-ELSEVIER. - 0002-8703 .- 1097-6744. ; 221, s. 60-66
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background High-density lipoprotein cholesterol (HDL-C) concentration is inversely related to risk of major adverse cardiovascular events (MACE) in epidemiologic studies but is a poorer predictor of MACE in patients with established coronary heart disease. HDL particle concentration (HDLP) has been proposed as a better predictor of risk. We investigated whether HDLP is associated with risk of MACE after acute coronary syndrome (ACS). Methods The dal-Outcomes trial compared the CETP inhibitor dalcetrapib with placebo in patients with recent ACS. In a nested case-cohort analysis, total, large, medium, and small HDLPs were measured by nuclear magnetic resonance spectroscopy at baseline (4-12 weeks after ACS) in 476 cases with MACE and 902 controls. Hazard ratios (HRs; case-control) for 1-SD increment of HDLP or HDL-C at baseline were calculated with and without adjustment for demographic, clinical, laboratory, and treatment variables. Similarly, HRs for MACE were calculated for changes in HDLP or HDL-C from baseline to month 3 of assigned treatment. Results Over median follow-up of 28 months, the risk of MACE was not associated with baseline HDLP (adjusted HR = 0.98, 95% CI = 0.84-1.15, P =.81), any HDLP subclass, or HDL-C. Dalcetrapib increased HDL-C and total, medium, and large HDLP and decreased small HDLP but had no effect on MACE compared with placebo. There were no association of risk of MACE with change in HDLP or HDL-C and no interaction with assigned study treatment. Conclusions Neither baseline HDLP nor the change in HDLP on treatment with dalcetrapib or placebo was associated with risk of MACE after ACS.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kardiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Salahuddin, Tauf ...
-
Kittelson, John
-
Tardif, Jean-Cla ...
-
Shah, Prediman K ...
-
Olsson, Anders, ...
-
Nicholls, Stephe ...
-
visa fler...
-
Leitersdorf, Era ...
-
Leiter, Lawrence ...
-
Kallend, David
-
Black, Donald M.
-
Barter, Philip J ...
-
Ballantyne, Chri ...
-
Schwartz, Gregor ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Kardiologi
- Artiklar i publikationen
-
American Heart J ...
- Av lärosätet
-
Linköpings universitet